These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7471390)

  • 1. Gas-chromatographic assay of free phenytoin in ultrafiltrates of plasma: test of a new filtration apparatus and specimen stability.
    Joern WA
    Clin Chem; 1981 Mar; 27(3):417-21. PubMed ID: 7471390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring phenytoin in salivary and plasma ultrafiltrates of pediatric patients.
    Bachmann K; Forney RB; Voeller K
    Ther Drug Monit; 1983; 5(3):325-9. PubMed ID: 6636260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid protein determinations on ultrafiltrates prepared for free phenytoin quantification.
    Turley CP; Milligan T
    Ther Drug Monit; 1985; 7(3):313-4. PubMed ID: 4049470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of phenytoin determinations in plasma, plasma dialysate and saliva for control of antiepileptic therapy in children.
    Brügmann G; Kleinau E; Nolte R; Petruch F
    Klin Wochenschr; 1979 Jan; 57(2):93-4. PubMed ID: 762949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.
    Barth N; Alván G; Borgå O; Sjöqvist F
    Clin Pharmacokinet; 1976; 1(6):444-52. PubMed ID: 1024769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
    Oellerich M; Müller-Vahl H
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of unbound phenytoin in the management of epilepsy.
    Kilpatrick CJ; Wanwimolruk S; Wing LM
    Br J Clin Pharmacol; 1984 May; 17(5):539-46. PubMed ID: 6733002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parotid and whole saliva in the prediction of serum total and free phenytoin concentrations.
    Anavekar SN; Saunders RH; Wardell WM; Shoulson I; Emmings FG; Cook CE; Gringeri AJ
    Clin Pharmacol Ther; 1978 Dec; 24(6):629-37. PubMed ID: 710022
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.
    Knott C; Hamshaw-Thomas A; Reynolds F
    Br Med J (Clin Res Ed); 1982 Jan; 284(6308):13-6. PubMed ID: 6797618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Amicon Centrifree micropartition system with the Sartorius SM 13249E Centrisart I device to determine protein free phenytoin concentrations.
    Zysset T; Zeugin T
    Ther Drug Monit; 1986; 8(3):346-51. PubMed ID: 3529518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin free fraction determination: comparison of an improved direct serum injection high-performance liquid chromatographic method to ultrafiltration coupled with fluorescence polarization immunoassay.
    Gurley BJ; Marx M; Olsen K
    J Chromatogr B Biomed Appl; 1995 Aug; 670(2):358-64. PubMed ID: 8548029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
    Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
    Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of phenytoin protein binding in epileptic patients.
    DeMonaco HJ; Lawless LM
    Arch Neurol; 1983 Aug; 40(8):481-3. PubMed ID: 6347141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous valproate: effects on plasma and saliva phenytoin levels.
    Pisani FD; Di Perri RG
    Neurology; 1981 Apr; 31(4):467-70. PubMed ID: 6783979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of equilibrium dialysis, ultrafiltration, and gel permeation chromatography for the determination of free fractions of phenobarbital and phenytoin.
    Melten JW; Wittebrood AJ; Willems HJ; Faber GH; Wemer J; Faber DB
    J Pharm Sci; 1985 Jun; 74(6):692-4. PubMed ID: 4020659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary phenytoin radioimmunoassay. A simple method of the assessment of non-protein bound drug concentrations.
    Paxton JW; Rowell F; Ratcliffe JG; Lambie DG; Nanda R; Melville ID; Johnson RH
    Eur J Clin Pharmacol; 1977; 11(1):71-4. PubMed ID: 832662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple isotope dilution electrospray ionization tandem mass spectrometry method for the determination of free phenytoin.
    Garg U; Peat J; Frazee C; Nguyen T; Ferguson AM
    Ther Drug Monit; 2013 Dec; 35(6):831-5. PubMed ID: 23942538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ultrafiltrate of saliva collected in situ as a biological sample for diagnostic evaluation.
    Schramm W; Smith RH
    Clin Chem; 1991 Jan; 37(1):114-5. PubMed ID: 1988190
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of ultrafiltrate volume on determination of free phenytoin concentration.
    McMillin GA; Juenke J; Dasgupta A
    Ther Drug Monit; 2005 Oct; 27(5):630-3. PubMed ID: 16175137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro-scale ultracentrifugation as an alternative to ultrafiltration for the determination of the unbound fraction of phenytoin in human serum.
    Jack L; Cunningham C; Watson ID; Stewart MJ
    Ann Clin Biochem; 1986 Sep; 23 ( Pt 5)():603-7. PubMed ID: 3532923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.